Unlock instant, AI-driven research and patent intelligence for your innovation.
Acetylenic sulfonamide thiol TACE inhibitors
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of butynyloxy and alkyl groups, applied in the preparation of thiols, active ingredients of amides, anti-inflammatory agents, etc., can solve the problems of bioavailability and pharmacokinetics.
Inactive Publication Date: 2005-10-26
WYETH HOLDINGS CORP
View PDF18 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Although a variety of TACE inhibitors are known, many of these molecules are peptides or peptoids, making their use difficult in terms of bioavailability and pharmacokinetics
Additionally, many of these molecules are nonselective as potent inhibitors of matrix metalloproteinases, especially MMP-1
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0170] 4-(2-Butynyloxy)-benzenesulfonic acid sodium salt
[0171] In a solution formed by 52.35g (0.225mol) of 4-hydroxybenzenesulfonic acid sodium salt in 1L of isopropanol and 225mL of 1.0N sodium hydroxide solution, add 59.96g (0.45mol) of 1-bromo-2-butane alkyne. The resulting mixture was heated to 70° for 15 hours, then the isopropanol was removed by evaporation in vacuo. The resulting white precipitate was collected by filtration, washed with isopropanol and diethyl ether, and dried in vacuo to yield 56.0 g (100%) of butynyl ether as a white solid.
Embodiment 2
[0173] 4-(2-Butynyloxy)-benzenesulfonyl chloride
[0174] 6.77mL (0.087mol) of DMF (N,N-dimethylformamide ), then add 7.24g (0.029mol) embodiment 1 product. The reaction mixture was stirred at 0° for 10 minutes, then allowed to warm to room temperature and stirred for 2 days. The reaction mixture was then poured into ice and extracted with 150 mL of hexane. The organics were washed with water and brine, washed with Na 2 SO 4 Drying, filtration, and concentration in vacuo yielded 6.23 g (88%) of yellow solid of sulfonyl chloride; mp 63-65° C., EI (electron impact) mass spectrometry: 243.9 (M + ).
Embodiment 3
[0176] 2-butynyloxy-benzene
[0177] In a solution formed by dissolving 6.14 g of triphenylphosphine (0.023 mol) in 100 mL of benzene and 40 mL of THF (tetrahydrofuran), 1.75 mL (0.023 mol) of 2-butyn-1-ol was added. After 5 minutes a solution of 2.00 (0.023 mol) phenol in 10 mL THF was added to the reaction mixture, followed by 3.69 mL (0.023 mol) of diethyl azodicarboxylate. The resulting reaction mixture was stirred at room temperature for 18 hours, then concentrated in vacuo. The residue was chromatographed on silica gel eluting with ethyl acetate / hexanes to give 2.18 g (70%) of butynyl ether as a clear liquid. EI (electron impact) mass spectrometry: 146.0MH + .
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Property
Measurement
Unit
melting point
aaaaa
aaaaa
Login to View More
Abstract
Compounds of formula (B): (1a), or (1b), (1c) are provided wherein the variables are as defined herein which are useful in disease conditions mediated by TNF- alpha , such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss.
Description
(1) Technical field [0001] The present invention relates to alkyaryl sulfonamide thiols as inhibitors of TNF-alpha converting enzyme (TACE). The compounds of the present invention are very useful in diseases mediated by TNF-α, such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss. (2) Background technology [0002] TNF-alpha converting enzyme (TACE) catalyzes the formation of TNF-alpha from membrane-bound TNF-alpha precursor protein. TNF-α is a pro-inflammatory cytokine, which is considered to play a major role in the following diseases: rheumatoid arthritis [Shire, M.G.; Muller, G.W.Exp.Opin.Ther.Patents 1998, 8 (5), 531; Grossman, J.M. Branhn, E.J. Woman's Health 1997, 6(6), 627; Isomaki, P.; Punnonen, J.Ann.Med.1997, 29, 499; Camussi, G.; Lupia, E. Drugs, 1998, 55(5), 613.], septic shock [Mathison et al. J. Clin. Invest. 1988, 81, 1925; Miethke et al. J. Exp. Med. 1992, 175, 9...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.